North Capital
EW icon

North Capital’s Edwards Lifesciences EW Stock Holding History

North Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$498K Buy
5,837
+551
+10% +$49K 0.36% 39
2026
Q2 		$478K Buy
5,286
+21
+0.4% +$1.76K 0.36% 42
2026
Q1 		$422K Hold
5,265
– – 0.36% 42
2025
Q4 		$449K Sell
5,265
-1
-0% -$82 0.39% 38
2025
Q3 		$410K Buy
5,266
+22
+0.4% +$1.72K 0.32% 42
2025
Q2 		$410K Hold
5,244
– – 0.35% 37
2025
Q1 		$380K Buy
+5,244
New +$375K 0.36% 39

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One North America
Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

North Capital's EW Position: Q3 2026 in Review

North Capital increased its Edwards Lifesciences (EW) stake by 10% in Q3 2026, buying an estimated $49K and bringing the position to 5,837 shares worth $498K. The position accounts for 0.36% of the portfolio, ranked #39.

North Capital first reported a position in EW in Q1 2025 and has held it in 7 quarters since. 468 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • North Capital held 5,837 shares of Edwards Lifesciences worth $498K as of Q3 2026.
  • North Capital bought 551 Edwards Lifesciences shares in Q3 2026, an estimated $49K.
  • Edwards Lifesciences made up 0.36% of North Capital's portfolio in Q3 2026, its #39 holding.
  • North Capital first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 7 quarters since.
  • 468 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on North Capital's 13F filing for Q3 2026, filed 16 Oct 2026.